Whole-body mri in oncology: can a single anatomic t2 dixon sequence replace the combination of t1 and stir sequences to detect skeletal metastasis and myeloma?

HIGHLIGHTS

• who: Ophelye Chiabai from the Department of Radiology and Medical Imaging, Cliniques (CHUV), Lausanne, Switzerland have published the research: Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?, in the Journal: (JOURNAL)

SUMMARY

Over recent years, whole-body magnetic_resonance imaging (WB-MRI) has demonstrated a high diagnostic performance and is now recommended in clinical guidelines for skeletal lesion detection and follow-up in patients with metastases from solid cancers and multiple myeloma (MM). Standard WB-MRI . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.